The pharmacological profile of ML3000: A new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase and 5-lipoxygenase

Author： Tries S.  

Publisher： VSP

ISSN： 1568-5608

Source： Inflammopharmacology, Vol.9, Iss.1-2, 2001-05, pp. : 113-124

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A pyrroloquinazoline derivative with anti-inflammatory and analgesic activity by dual inhibition of cyclo-oxygenase-2 and 5-lipoxygenase

By Rioja I.   Terencio M.C.   Ubeda A.   Molina P.   Tarraga A.   Gonzalez-Tejero A.   Alcaraz M.J.  

European Journal of Pharmacology, Vol. 434, Iss. 3, 2002-01 ,pp. : 177-185

Elsevier

Access to resources Recommend Favorite

Inhibition of cyclo-oxygenase and lipoxygenase reviewed

By  

Inpharma, Vol. 1, Iss. 1317, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Thrombin-stimulated DNA Synthesis in Human Cultured Airway Smooth Muscle Occurs Independently of Products of Cyclo-oxygenase or 5-Lipoxygenase

By Fernandes D.   Vlahos R.   Stewart A.G.  

Pulmonary Pharmacology & Therapeutics, Vol. 13, Iss. 5, 2000-09 ,pp. : 241-248

Academic Press

Access to resources Recommend Favorite

Pharmacological Intervention of Cyclooxygenase-2 and 5-Lipoxygenase Pathways. Impact on Inflammation and Cancer

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3431-3447

Bentham Science Publishers

Access to resources Recommend Favorite

New Approaches to the Modulation of the Cyclooxygenase-2 and 5-Lipoxygenase Pathways

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 3, 2007-02 ,pp. : 297-309

Bentham Science Publishers

Access to resources Recommend Favorite